Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
47 hedge funds and large institutions have $9.94M invested in Chembio diagnostics, Inc. in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 21 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
22% less funds holding
Funds holding: 60 → 47 (-13)
31% less capital invested
Capital invested by funds: $14.4M → $9.94M (-$4.47M)
48% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $2M
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$498K |
| 2 |
Morgan Stanley
New York
|
+$238K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$197K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$196K |
| 5 |
BlackRock
New York
|
+$189K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$978K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$796K |
| 3 |
Millennium Management
New York
|
-$559K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$324K |
| 5 |
E
Ergoteles
New York
|
-$267K |
CEMI Hedge Fund Activity: Q3 2021 in Review
47 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2021, worth a combined $9.94M — down 31% from $14.4M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of CEMI and 8 opened new positions — a net loss of 13 holders — while 14 trimmed existing stakes and 17 added.
The largest buyer was Susquehanna Fundamental Investments, opening a new position worth an estimated $498K. The largest seller was Segall Bryant & Hamill, cutting an estimated $978K.
- 47 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2021, down from 60 in Q2 2021.
- Funds reported $9.94M of Chembio diagnostics, Inc. stock for Q3 2021, down 31% quarter-over-quarter.
- 8 funds opened new Chembio diagnostics, Inc. positions in Q3 2021 and 21 closed out, a net change of -13 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2021 was Susquehanna Fundamental Investments, an estimated $498K added.
- The largest Chembio diagnostics, Inc. seller in Q3 2021 was Segall Bryant & Hamill, an estimated $978K sold.
Based on aggregated 13F filings for Q3 2021.